Related Experiment Video
Updated: Aug 20, 2026

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
Development of a commercial amperometric biosensor electrode for the ketone D-3-hydroxybutyrate
Nigel J Forrow1, Gurdial S Sanghera, Stephen J Walters
1MediSense Products, Abbott Diabetes Care, Abbott Laboratories, Range Road, Witney, Oxon OX29 0YL, UK. nigel.forrow@abbott.com
Abstract:
Representatives of the common classes of quinoid NADH redox mediator, including Meldola Blue (MB) 3, 4-methyl-1,2-benzoquinone (4-MBQ) 4, 1-methoxy phenazine methosulphate (1-MeO-PMS) 5 and 2,6-dichloroindophenol (DCIP) 6, are shown to inhibit the NAD-dependent enzyme D-3-hydroxybutyrate dehydrogenase (HBDH), severely limiting their utility in the construction of a stable biosensor electrode for the ketone body D-3-hydroxybutyrate (3-OHB). It is proposed that these mediators bind covalently to important thiol groups in the enzyme. This mode of inhibition is overcome through the use of mediators such as 1,10-phenanthroline quinone (1,10-PQ) 7, which avoid 1,4-nucleophilic addition with enzyme amino acid residues such as Cys. As a result, 1,10-PQ 7 was selected for incorporation in a biosensor electrode for 3-OHB. The resulting MediSense Optiumtrade mark beta-Ketone electrode is stable (
Related Concept Videos
Amperometry: Overview
Potentiometry: Membrane Electrodes
Electrodeposition
Electrodeposition can...

